Ardelyx, Inc. (ARDX) Stock Price, Quote & AI Analysis

Live ARDX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Ardelyx, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Ardelyx, Inc. (ARDX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

ARDX
Ardelyx, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$1,494,527,791.35
52W Range
$3.49 - $8.40
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 3, 2026 Q2
Market
EPS Estimate: $-0.0222
Revenue Estimate: $130,915,235.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Ardelyx, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Ardelyx, Inc. Overview

Company information

Company Overview

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Company Details
Market Cap
$1.49B
Shares Outstanding
247,029,394
Weighted Shares Outstanding
247,029,387
CEO
Michael G. Raab
Address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Employees
489
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Ardelyx, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...